Search clinical trials for: Preclinical Alzheimer's disease

Total 381857 results

Yuanjiao Yan

Recruiting

Cognitive Leisure and Preclinical Alzheimer's Disease: Exploring Neural Mechanisms

Cognitive Dysfunction

China
Skane University Hospital
Lund University

Recruiting

The Swedish BioFINDER - Preclinical AD Study

Alzheimer Disease | Mild Cognitive Impairment | Mild Dementia

Sweden
University of Southern California
Alzheimer's Therapeutic Research Institute; American Heart Association; Schaeffer...

Recruiting

Financial Incentives and Recruitment to the APT Webstudy (FIND-AD)

Dementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's Disease

United States
Massachusetts General Hospital

Recruiting

Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

Healthy Aging | Mild Cognitive Impairment | Subjective Cognitive Concerns | Mild Behavioral Impairment

United States
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension (FUTURE-US)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United States
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension (PAST-US)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease | Normal Cognition

United States
Barcelonabeta Brain Research Center, Pasqual Maragall...

Recruiting

β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline (β-AARC)

Alzheimer Disease | Mild Cognitive Impairment | Preclinical Alzheimer

Spain
Novoic Limited

Not yet recruiting

Prediction of Amyloid and Mild Cognitive Impairment in Early Stage Alzheimer's Disease From Remote Speech Phenotyping (EARS)

Alzheimer Disease | Mild Cognitive Impairment | Alzheimer's Disease (Incl Subtypes)
Massachusetts General Hospital
National Institute on Aging (NIA)

Recruiting

The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive Performance (WALLe)

Aging

United States
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension (AMYPRED-PAST)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United Kingdom
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension (AMYPRED-FUTURE)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United Kingdom
Eisai Inc.
National Institute on Aging (NIA); Biogen; Alzheimer's Clinical Trials Consortium

Recruiting

AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

Preclinical Alzheimer's Disease | Early Preclinical Alzheimer's Disease

United States, Singapore, Canada, Spain, Australia, Japan, United Kingdom, Sweden, Netherlands
Massachusetts General Hospital

Recruiting

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

Alzheimer Disease | Aging | Mild Cognitive Impairment

United States
Tammie L. S. Benzinger, MD, PhD

Recruiting

Imaging Biomarkers in Preclinical and Symptomatic AD (ACS_PIB_IND)

Alzheimer Disease

United States
University of Rhode Island
Stuart Sinoff, MD; Peter J Snyder, MD; BayCare Health System

Recruiting

Atlas of Retinal Imaging in Alzheimer's Study (ARIAS)

Cognitive Change | Alzheimer Disease | Aging | Mild Cognitive Impairment | Mild Dementia

United States
University of Southern California
National Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Alzheimer's Clinical Trials Consortium (ACTC)

Enrolling by invitation

Alzheimer's Plasma Extension (APEX)

Preclinical Alzheimer's Disease | Early Preclinical Alzheimer's Disease

United States
University of Southern California
National Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Brigham and Women's Hospital and other collaborators

Active, not recruiting

TRC-PAD Program: In-Clinic Trial-Ready Cohort (TRC-PAD)

Dementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's Disease

United States
Hoffmann-La Roche
National Institute on Aging (NIA); Banner Alzheimer's Institute

Completed

Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease

Alzheimer Disease

Colombia
University of Colorado, Denver
American College of Radiology

Completed

Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetes, Youth Onset

United States
University of Tasmania

Enrolling by invitation

TapTalkTest Project:Development of a Non-invasive Screening Test to Detect Risk of Alzheimer's Disease Pathology (TapTalkTest)

Dementia | Alzheimer Disease | Speech Disorders | Movement Abnormalities

Australia
Genentech, Inc.
National Institute on Aging (NIA); Banner Alzheimer's Institute

Completed

A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort

Alzheimer's Disease

Colombia
XuanwuH 2

Completed

Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD

Subjective Cognitive Decline | Preclinical Alzheimer's Disease

China
Washington University School of Medicine
National Institute on Aging (NIA)

Enrolling by invitation

Falls: A Marker of Preclinical AD

Alzheimer Disease | Fall

United States
Medical College of Wisconsin
National Institute on Aging (NIA)

Completed

Network-Level Mechanisms for Preclinical Alzheimer's Disease Development

APOE 4

United States
New York State Psychiatric Institute
University of Miami; Columbia University; University of Southern California; Feinstein...

Active, not recruiting

Development of Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD)

Healthy Participants

United States
Weill Medical College of Cornell University
National Institute on Aging (NIA)

Completed

PET Measures of CSF Clearance in Preclinical Alzheimer's Disease

Mild Cognitive Impairment

United States
University of Minnesota

Completed

Concurrent Aerobic Exercise and Virtual Reality Cognitive Training (VRCT)

Preclinical Alzheimer's Disease

United States
Novoic Limited

Completed

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping (AMYPRED-US)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United States
Novoic Limited

Completed

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech (AMYPRED)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United Kingdom
Novartis Pharmaceuticals
Amgen; Banner Alzheimer's Institute

Terminated

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GS2)

Alzheimers Disease

Spain, United States, Belgium, Italy, Germany, Australia, Israel, Taiwan, Japan, Canada, Korea, Republic of, United Kingdom, France, China, Argentina, Finland, Singapore, Portugal, Chile, Mexico, Switzerland, Netherlands, Iceland, Puerto... and more
Novartis Pharmaceuticals
National Institute on Aging (NIA); Amgen; Banner Alzheimer's Institute

Terminated

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GS1)

Alzheimers Disease

United States, Belgium, United Kingdom, Germany, Australia, Canada, Spain, Finland, Switzerland, Netherlands
Barcelonabeta Brain Research Center, Pasqual Maragall...
Obra Social La Caixa, Spain

Completed

Study for Cognitive and Genetic Characterization of a 45-65 Years Old Population

Healthy Individuals

Spain
Judit Pich Martínez

Terminated

Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study

Alzheimer Disease

Spain
Avid Radiopharmaceuticals

Completed

Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

Alzheimer Disease | Mild Cognitive Impairment
XuanwuH 2
Beijing Institute of Technology

Completed

Neurofeedback Intervention for Preclinical Alzheimer's Disease

Alzheimer Disease | Electroencephalogram | Neurofeedback | Subjective Cognitive Decline

China
XuanwuH 2

Completed

Non-pharmacological Intervention for Preclinical Alzheimer's Disease

Alzheimer Disease | Intervention | Subjective Cognitive Decline | Neuroimaging | Functional Food

China
Gregory Jicha, 323-5550

Completed

Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease

Preclinical Alzheimer's Disease

United States
Carmel Medical Center

Unknown

Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease? (SCI-OCT)

Alzheimer's Disease

Israel
National Institute on Aging (NIA)

Unknown

PET Changes in Alzheimer's Disease (AD)

Alzheimer Disease

United States
MTI Biotech Inc
Vanderbilt University Medical Center

Not yet recruiting

2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients (2-HOBA)

Alzheimer Disease | Mild Cognitive Impairment

United States
Ba Yi
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma

Biliary Tract Carcinoma

China
Spinogenix

Not yet recruiting

Safety, Tolerability, and Efficacy of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)

Alzheimer Disease
St. Joseph's Hospital and Medical Center, Phoenix
Mayo Clinic; Arizona State University; Karlsruhe Institute of Technology

Recruiting

Time Restricted Eating in Alzheimer's Disease (TREAD) (TREAD)

Intermittent Fasting

United States
Icahn School of Medicine at Mount Sinai
National Institute on Aging (NIA)

Recruiting

Resilient Together for Dementia (RT-D ADRD)

Alzheimer's Disease and Related Dementias

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Validation of a Preclinical Model Based on Patient-derived Organoids for the Study of the Gut-joint Axis in Spondyloarthritis (ORGANOSPA)

Inflammatory Bowel Diseases | Spondyloarthritis

Italy
Shanghai University of Traditional Chinese Medicine
Shanghai Minimally Invasive Surgery Center

Not yet recruiting

Clinical Evaluation of Acupuncture Treatment on Alzheimer's Disease in APOE e4 Carriers and Non-Carriers

Cognitive Impairment | Alzheimer Disease

China
University of Haifa
Bnai Zion Medical Center; Clalit Health Services, Haifa and West Galilee

Not yet recruiting

Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL) (MBL RiskConseq)

Cardiovascular Diseases | Infections | Autoimmune Diseases | Parkinson Disease | Dementia | Alzheimer Disease | Chronic Lymphocytic Leukemia | Monoclonal B-Cell Lymphocytosis | Cancers
Istituto Superiore di Sanità

Not yet recruiting

Dementia in Migrants Living in Italy: Promoting a Diversity-sensitive Clinical Approach and Provision of Care

Dementia | Alzheimer Disease
Keymed Biosciences Co.Ltd

Not yet recruiting

Single Dose Escalation Study of CM383 in Healthy Volunteers

Alzheimer Disease
University of Washington
National Institute on Aging (NIA)

Not yet recruiting

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors (SLEEP-COG)

Delirium | Critical Illness | Cognitive Impairment | Dementia | Sleep Disturbance | Cognitive Decline | Alzheimer's Disease | Circadian Dysrhythmia

Search clinical trials for: Preclinical Alzheimer's disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations